Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia

Systemic lupus erythematosus (SLE) is an autoimmune disease that leads to a wide spectrum of clinical and immunological abnormalities. Hematologic abnormalities are an important manifestation of SLE. The incidence of autoimmune hemolytic anemia (AIHA) has been reported in approximately 10% of patien...

Full description

Bibliographic Details
Main Authors: Eiji Suzuki, Takashi Kanno, Yurie Saito, Takuro Shimbo
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2023/4963196
_version_ 1797672809207431168
author Eiji Suzuki
Takashi Kanno
Yurie Saito
Takuro Shimbo
author_facet Eiji Suzuki
Takashi Kanno
Yurie Saito
Takuro Shimbo
author_sort Eiji Suzuki
collection DOAJ
description Systemic lupus erythematosus (SLE) is an autoimmune disease that leads to a wide spectrum of clinical and immunological abnormalities. Hematologic abnormalities are an important manifestation of SLE. The incidence of autoimmune hemolytic anemia (AIHA) has been reported in approximately 10% of patients with SLE. Among them, mixed-type AIHA, which is caused by warm autoantibodies and cold hemagglutinin, is relatively rarely reported. We report the case of a 72-year-old woman, who was admitted to our hospital due to shortness of breath, jaundice, and severe anemia, with SLE and antiphospholipid syndrome (APS) complicated by mixed-type AIHA. Laboratory data revealed severe hemolytic anemia (low hemoglobin, high indirect bilirubin, and high lactate dehydrogenase levels), low complement levels, and the presence of antinuclear antibodies and lupus anticoagulant. Imaging results revealed pleural effusion and pulmonary embolisms, and echocardiogram revealed high estimated right ventricular pressure. She was diagnosed with SLE and APS complicated by mixed-type AIHA based on positive direct antiglobulin and cold agglutinin tests (thermal amplitude ≥30°C). As mixed-type AIHA is a severe and chronic condition, she was administered potent treatments with immunosuppressants. However, because she was a carrier of human T-cell leukemia virus type-1, only a moderate amount of prednisolone was administered. She refused to take warfarin. Fortunately, her symptoms and laboratory abnormalities improved after prednisolone administration, and no relapse occurred after tapering the prednisolone dose. Although mixed-type AIHA is characterized by fewer clinical symptoms than cold agglutinin disease, hemolytic anemia is more severe and chronic. Therefore, it is important to confirm the presence of cold agglutinins, which are active at ≥30°C in patients with SLE and warm AIHA. In addition, it is important to consider that AIHA is associated with thromboembolism, and patients with lupus anticoagulant or anticardiolipin antibodies having a history of AIHA are at a high risk of developing thrombosis.
first_indexed 2024-03-11T21:35:35Z
format Article
id doaj.art-32f68be3bad54a6f84e6101ab990ecfa
institution Directory Open Access Journal
issn 2090-6897
language English
last_indexed 2024-03-11T21:35:35Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Case Reports in Rheumatology
spelling doaj.art-32f68be3bad54a6f84e6101ab990ecfa2023-09-27T00:00:02ZengHindawi LimitedCase Reports in Rheumatology2090-68972023-01-01202310.1155/2023/4963196Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic AnemiaEiji Suzuki0Takashi Kanno1Yurie Saito2Takuro Shimbo3Department of RheumatologyDepartment of RheumatologyDepartment of HematologyDepartment of Internal MedicineSystemic lupus erythematosus (SLE) is an autoimmune disease that leads to a wide spectrum of clinical and immunological abnormalities. Hematologic abnormalities are an important manifestation of SLE. The incidence of autoimmune hemolytic anemia (AIHA) has been reported in approximately 10% of patients with SLE. Among them, mixed-type AIHA, which is caused by warm autoantibodies and cold hemagglutinin, is relatively rarely reported. We report the case of a 72-year-old woman, who was admitted to our hospital due to shortness of breath, jaundice, and severe anemia, with SLE and antiphospholipid syndrome (APS) complicated by mixed-type AIHA. Laboratory data revealed severe hemolytic anemia (low hemoglobin, high indirect bilirubin, and high lactate dehydrogenase levels), low complement levels, and the presence of antinuclear antibodies and lupus anticoagulant. Imaging results revealed pleural effusion and pulmonary embolisms, and echocardiogram revealed high estimated right ventricular pressure. She was diagnosed with SLE and APS complicated by mixed-type AIHA based on positive direct antiglobulin and cold agglutinin tests (thermal amplitude ≥30°C). As mixed-type AIHA is a severe and chronic condition, she was administered potent treatments with immunosuppressants. However, because she was a carrier of human T-cell leukemia virus type-1, only a moderate amount of prednisolone was administered. She refused to take warfarin. Fortunately, her symptoms and laboratory abnormalities improved after prednisolone administration, and no relapse occurred after tapering the prednisolone dose. Although mixed-type AIHA is characterized by fewer clinical symptoms than cold agglutinin disease, hemolytic anemia is more severe and chronic. Therefore, it is important to confirm the presence of cold agglutinins, which are active at ≥30°C in patients with SLE and warm AIHA. In addition, it is important to consider that AIHA is associated with thromboembolism, and patients with lupus anticoagulant or anticardiolipin antibodies having a history of AIHA are at a high risk of developing thrombosis.http://dx.doi.org/10.1155/2023/4963196
spellingShingle Eiji Suzuki
Takashi Kanno
Yurie Saito
Takuro Shimbo
Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
Case Reports in Rheumatology
title Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
title_full Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
title_fullStr Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
title_full_unstemmed Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
title_short Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
title_sort systemic lupus erythematosus and antiphospholipid syndrome accompanied by mixed type autoimmune hemolytic anemia
url http://dx.doi.org/10.1155/2023/4963196
work_keys_str_mv AT eijisuzuki systemiclupuserythematosusandantiphospholipidsyndromeaccompaniedbymixedtypeautoimmunehemolyticanemia
AT takashikanno systemiclupuserythematosusandantiphospholipidsyndromeaccompaniedbymixedtypeautoimmunehemolyticanemia
AT yuriesaito systemiclupuserythematosusandantiphospholipidsyndromeaccompaniedbymixedtypeautoimmunehemolyticanemia
AT takuroshimbo systemiclupuserythematosusandantiphospholipidsyndromeaccompaniedbymixedtypeautoimmunehemolyticanemia